Clinical Trial Update: Costa Rican Registry of IL-23 Inhibitors in Psoriatic Disease

View source ↗

Summary

A Costa Rican registry study evaluating IL-23 inhibitors for psoriasis and psoriatic arthritis; the trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis
• Psoriatic Arthritis

Snippet

Sponsor: Caja Costarricense de Seguro Social | Conditions: Psoriasis, Psoriasis Arthritis | Status: NOT_YET_RECRUITING